Study indicates that demand for unit dose blister packaging will increase in the future

The Freedonia Group study indicates that the demand for single-dose packaging systems will grow in the future. Photo credit: Jakayla Toney on Unsplash

Patient adherence, injection prevention, increased drug production and self-administration are some of the key drivers behind the estimated 6.4% annual growth of unit dose containers, and it is expected to reach $57.9 billion by the end of 2025, according to new analysis from Freedonia Group.

The blister packaging for solid dose applications will dominate the global market. Parenteral vials and pre-fillable syringes will see the fastest growth. Improving patient compliance through package design is one of the significant trends supporting the unit dose market. This will speed up the use of pads and pads. Clinical drug trials will drive growth prospects for unit-dose packaging systems that promote record keeping and compliance.

The Freedonia Group the analysis predicts that due to the increased need for better infection control systems, the use of adaptable pen cartridges, self-retracting pre-fillable syringes and high barrier parenteral vials would increase in the global medical community. It is a response to the need to improve infection prevention systems.

Bulb growth is driven by competition

Increasing competition between private label and generic is driving drug manufacturers to improve packaging to influence the purchasing decisions of medical providers and consumers.

According to Freedonia analyst Bill Martineau, downward pricing pressures imposed by private and public health insurers are driving competition between individual and general brands. In addition, due to acquisitions and mergers, the number of exclusive drug distributors and manufacturers is slightly decreasing and the number of generic distributors and producers is increasing.

Efforts to improve the convenience and aesthetic properties of pharmaceutical packaging apply overwhelmingly to over-the-counter supplements and medications sold in retail stores. Additionally, enhancements to ethical drug packaging include ease of delivery and infection prevention features.

Vaccines and new therapies require unit dose syringes

According to the study, biosimilar and new treatments for viral diseases, cancer and several other debilitating conditions will drive the demand for parenteral unit dose vials and pre-fillable syringes. Martineau says that all of these medications are almost always packaged in unit dose containers.

Additionally, current improvements in syringe safety and design are responsible for the increase in therapies approved for self-injection. Hence, this is accelerating the demand for parenteral unit dose vials and pre-fillable syringes. According to Martineau, self-injection therapies are mostly packaged in multi-use devices with single-dose cartridges or syringes.

The increased focus on infection prevention in the parenteral drug delivery system in clinics, hospitals, nursing homes, and physicians’ offices is also contributing to the rise of single-dose parenteral vials and syringes. unitary.

In conclusion, the demand for all these unit formats will increase. It will be the answer to the expansion of global preventive medicine that needs a single-dose, injectable vaccine for diseases like shingles, meningitis, influenza and Covid-19. The medical sector is making drastic progress. So, in the next few years, it will elevate things to a whole new level. With advancements in technology and increased consumer demand, things are going to intensify very soon.

The Covid-19 pandemic led to the nationwide lockdown on March 25, 2020. It will be two years tomorrow as I write this. What have we learned during this time? Perhaps the sense of resilience as small businesses like ours have had to rely on our resources and the forbearance of our employees as we struggled to produce our business platforms.

The printing and packaging industries have been lucky, although the commercial printing industry has yet to recover. We learned about the digital transformation affecting commercial printing and packaging. Ultimately, digital will help print grow in a country where we are still far behind in our paper and print consumption and where digital is an advanced technology that will only increase the demand for printing for the foreseeable future.

Web analytics show that we now have readership in North America and Europe among the 90 countries where our five platforms are present. Our traffic, which more than doubled in 2020, sometimes increased by 50% in 2021. And advertising, which had collapsed in 2020 and 2021, began to come back in January 2022.

As the economy approaches real growth with irregularities and shortages, we look forward to the PrintPack India exhibition in Greater Noida. We are again mandated to produce the Show Daily over the five days of the show from May 26 to 30, 2022.

Now is a good time to support our high-impact reporting and authoritative, technical information with some of the best correspondents in the industry. Readers can contribute to Packaging South Asia’s balanced industry journalism and help support us by subscribing.

– Naresh Khanna

Subscribe now

About Yvonne Lozier

Check Also

SEC modernizes record-keeping requirements for certain registrants

On October 12, the Securities and Exchange Commission (SEC) voted to adopt a new electronic …